期刊文献+

鲍曼不动杆菌血流感染预后危险因素分析 被引量:12

Risk factors for fatality of Acinetobacter baumannii bloodstream infection
原文传递
导出
摘要 目的 探讨影响鲍曼不动杆菌血流感染预后的危险因素及菌株耐药情况.方法 回顾性分析2011年1月至2014年5月天津医科大学总医院80例血流感染鲍曼不动杆菌住院患者的资料,包括年龄、性别、入住科室、基础疾病、治疗、有创操作、细菌耐药性和入院时急性生理学与慢性健康状况评分系统Ⅱ(APACHEⅡ)评分.采用多因素Logistic回归分析影响预后的相关因素.结果 80株鲍曼不动杆菌对头孢他啶、头孢曲松,头孢西丁的耐药率高达90%以上,对亚胺培南的耐药率为66.3%,对头孢哌酮/舒巴坦以及替加环素的耐药率较低,分别为7.5%和2.5%.入住ICU[优势比(OR)=6.67,95%可信区间(95% CI)为2.01 ~ 22.07,P<0.01],多重耐药(OR=3.55,95% CI为1.30~9.69,P<0.05),APACHEⅡ评分≥19(OR=39.00,95% CI为9.87 ~ 154.09,P<0.01),动脉插管(OR=3.24,95% CI为1.16~9.04,P<0.05),中央静脉插管(OR=3.33,95% CI为1.22 ~9.12,P<0.05),气管插管(OR=3.60,95% CI为1.31 ~9.88,P<0.05),气管切开(OR =3.21,95% CI为1.19 ~8.66,P<0.05),其他有创操作(OR =3.00,95% CI为1.11~ 8.08,P<0.05)为鲍曼不动杆菌血流感染患者死亡的危险因素.结论 侵入性操作与细菌的耐药性会增加鲍曼不动杆菌血流感染患者的病死率. Objective To investigate the antibiotic resistance of Acinetobacter baumannii,and to identify the risk factors for fatality of Acinetobacter baumannii bloodstream infection.Methods A retrospective review was conducted on 80 patients with Acinetobacter baumannii bloodstream infections admitted in Tianjin General Hospital during January 2011 to May 2014.Clinical data including demographic information,the ward of stay,underlying diseases,treatment,invasive procedures,antibiotic resistance,acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ) score at admission were collected.Multivariate Logistic regression analysis was performed to identify the risk factors for fatality.Results There were ≥90% strains resistant to ceftazidime,ceftriaxone and cefoxitin,and 66.3% strains were resistant to imipenem.While most strains were sensitive to cefoperazone/shubatan and tigecycline,and the resistance rates were 7.5% and 2.5%,respectively.ICU admission (OR =6.67,95% CI:2.01-22.07,P <0.01),multi-drug resistance (OR =3.55,95% CI:1.30-9.69,P < 0.05),APACHE Ⅱ score ≥ 19 (OR =39.00,95% CI:9.87-154.09,P < 0.01),artery catheterization (OR =3.24,95% CI:1.16-9.04,P < 0.05),central venous catheterization (OR =3.33,95% CI:1.22-9.12,P < 0.05),tracheal catheterization (OR=3.60,95%CI:1.31-9.88,P<0.05),tracheostomy (OR=3.21,95%CI:1.19-8.66,P<0.05),and other invasive procedures (OR =3.00,95% CI:1.11-8.08,P < 0.05) were the risk factors for fatality.Conclusion Invasive procedures and multi-drug resistance are associated with increased fatality of patients with Acinetobacter baumannii bloodstream infection.
出处 《中华临床感染病杂志》 CAS 2014年第5期401-404,共4页 Chinese Journal of Clinical Infectious Diseases
关键词 鲍氏不动杆菌 危险因素 抗药性 血流感染 急性生理学与慢性健康状况评分系统Ⅱ Acinetobacter baumannii Risk factors Drug resistance Bloodstream infection Acute physiology and chronic health evaluation Ⅱ
  • 相关文献

参考文献14

二级参考文献47

  • 1周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:241
  • 2李星明,陈景武.儿童智力低下危险因素研究中1:1配对Logistic回归的方法适应性检验[J].数理医药学杂志,2005,18(4):342-345. 被引量:5
  • 3罗百灵,王丽静,胡成平,戴文鑫.1995-2004年下呼吸道感染病原菌变迁[J].中国感染与化疗杂志,2006,6(3):182-185. 被引量:34
  • 4汪复.多重耐药铜绿假单胞菌与鲍曼不动杆菌严重感染的防治策略[J].中国感染与化疗杂志,2007,7(3):230-232. 被引量:139
  • 5Towner K J. Clinical importance and antibiotic resisiance of Acinetobacter spp. Proceedings of a symposium held on 4 - 5 November 1996 at Eilat. Israel[J]. J Med Microbial, 1997, 46:721 - 746.
  • 6Gilbert R,Moellering R Jr,Eliopoulos G,et al. TheSanford Guide to Antimierobial Therapy 2008 (38th edition ) [M ]. Sperryville, VA, USA : Antimicrobial Therapy lnc, 2008.
  • 7Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii:emergence of a successful pathogen. Clin Microbiol Rev, 2008,21 : 538-582.
  • 8Waites KB, Duffy LB, Dowzicky MJ. Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimierobial. Antimicrob Agents Chemother,2006 ,50 :3479-3484.
  • 9Guner R, Hasanoglu I, Keske S, et al. Outcome in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy. Infection, 2011,39: 515-518.
  • 10Hoban D J, Bouchillon SK, Dowzicky MJ. Antimicrobial susceptibility of extended-spectrum-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial. Diagn Microbiol Infect Dis ,2007,57:423-428.

共引文献1120

同被引文献65

引证文献12

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部